These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26043775)

  • 1. Identification of key genes and pathways in renal cell carcinoma through expression profiling data.
    Liu X; Wang J; Sun G
    Kidney Blood Press Res; 2015; 40(3):288-97. PubMed ID: 26043775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of feature genes of the renal cell carcinoma with DNA microarray.
    Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray profiling of human renal cell carcinoma: identification for potential biomarkers and critical pathways.
    Li W; Zhu W; Che J; Sun W; Liu M; Peng B; Zheng J
    Kidney Blood Press Res; 2013; 37(4-5):506-13. PubMed ID: 24247930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
    Qu W; Han C; Li M; Zhang J; Li L
    Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
    Wu F; Wu S; Gou X
    Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identified differently expressed genes in renal cell carcinoma by using multiple microarray datasets running head: differently expressed genes in renal cell carcinoma.
    Cheng Y; Hong M; Cheng B
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1033-40. PubMed ID: 24763884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome network analysis reveals candidate genes for renal cell carcinoma.
    Zhai W; Xu YF; Liu M; Zheng JH
    J Cancer Res Ther; 2012; 8(1):28-33. PubMed ID: 22531510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of the estrogen receptor target genes in renal cell carcinoma.
    Liu Z; Lu Y; He Z; Chen L; Lu Y
    Mol Med Rep; 2015 Jan; 11(1):75-82. PubMed ID: 25351113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
    Guan L; Tan J; Li H; Jin X
    Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
    J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In search of key genes associated with endometriosis using bioinformatics approach.
    Liu F; Lv X; Yu H; Xu P; Ma R; Zou K
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():119-24. PubMed ID: 26366788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
    Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network.
    Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G
    J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network spatio-temporal analysis predicts disease stage-related genes and pathways in renal cell carcinoma.
    Li1 XH; Yang CZ; Wang J
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique.
    He TL; Zheng KL; Li G; Song B; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2014; 18(1):108-16. PubMed ID: 24452951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
    Wu T; Li Q; Wu T; Liu HY
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
    Wang Y; Wang Y; Liu F
    Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.